Literature DB >> 21414734

Management of bovine tuberculosis in Michigan wildlife: current status and near term prospects.

Daniel J O'Brien1, Stephen M Schmitt, Scott D Fitzgerald, Dale E Berry.   

Abstract

Surveillance and control activities for bovine tuberculosis (bTB) in free-ranging Michigan white-tailed deer (Odocoileus virginianus) have now been underway for over a decade. Significant progress has been made, lowering apparent prevalence in deer in the core area by >60%, primarily via reduction of deer densities through hunting, and restrictions on public feeding and baiting of deer. These broad strategies of the Michigan Department of Natural Resources (MDNR), implemented with the cooperation of Michigan deer hunters, halved the deer population in the bTB endemic area. However, as hunters see fewer deer, their willingness to sustain aggressive harvests has waned, and public resentment of control measures has grown. During the past four years, apparent prevalence in core area deer has held approximately steady just below 2%. After bottoming out in 2004 at an estimated 10-12 deer/km(2), deer numbers have since rebounded by ∼ 30%. Public compliance with baiting and feeding restrictions has been variable. In general, hunters in the core area do not perceive bTB as a problem, in spite of 13 years of MDNR outreach. To date, MDNR has expended more than US$23 million on TB-related activities. Of late, a substantial portion of that funding has been diverted to support other programs which have suffered from budget shortfalls. Livestock herd breakdowns continue to occur sporadically, averaging 3-4 per year 2005 to present. In total, 46 cattle and 4 captive deer herds have been diagnosed bTB positive statewide, the majority yielding only 1 positive animal. Five cattle herds were twice infected, one thrice. Michigan Department of Agriculture (MDA) policy emphasis has shifted towards obtaining producer support for wildlife risk mitigation and farm biosecurity. Funding has proven a limiting factor, with the majority of the US$63 million spent to date devoted to whole herd testing. Nevertheless, some initiatives justify cautious optimism. Promising research to support eventual vaccination of wild deer continues. Some hunters and landowners have begun to recognize the costs of high deer densities and supplemental feeding. A peninsula-wide ban on baiting and feeding was enacted. Some cattle producers, recognizing their precarious circumstances, have begun work to change long-held prevailing opinions among their peers about farm biosecurity. Yet formidable challenges remain, and evidence suggests that eradication of bTB, if it can be achieved, will take decades, and will require greater public and political resolve than has been demonstrated thus far.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21414734     DOI: 10.1016/j.vetmic.2011.02.042

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  19 in total

1.  Comparison of PCR versus culture for detection of Mycobacterium bovis after experimental inoculation of various matrices held under environmental conditions for extended periods.

Authors:  Angela P Adams; Steven R Bolin; Amanda E Fine; Carole A Bolin; John B Kaneene
Journal:  Appl Environ Microbiol       Date:  2013-08-16       Impact factor: 4.792

2.  Identification of Novel Seroreactive Antigens in Johne's Disease Cattle by Using the Mycobacterium tuberculosis Protein Array.

Authors:  John P Bannantine; Joseph J Campo; Lingling Li; Arlo Randall; Jozelyn Pablo; Craig A Praul; Juan Antonio Raygoza Garay; Judith R Stabel; Vivek Kapur
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

3.  Rapid detection of serum antibody by dual-path platform VetTB assay in white-tailed deer infected with Mycobacterium bovis.

Authors:  Konstantin P Lyashchenko; Rena Greenwald; Javan Esfandiari; Daniel J O'Brien; Stephen M Schmitt; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

Review 4.  Mycobacterium bovis (bovine tuberculosis) infection in North American wildlife: current status and opportunities for mitigation of risks of further infection in wildlife populations.

Authors:  R S Miller; S J Sweeney
Journal:  Epidemiol Infect       Date:  2013-05-09       Impact factor: 4.434

Review 5.  The epidemiology of Mycobacterium bovis in wild deer and feral pigs and their roles in the establishment and spread of bovine tuberculosis in New Zealand wildlife.

Authors:  G Nugent; C Gortazar; G Knowles
Journal:  N Z Vet J       Date:  2015-03-23       Impact factor: 1.628

6.  Surveillance of bovine tuberculosis and risk estimation of a future reservoir formation in wildlife in Switzerland and Liechtenstein.

Authors:  Janne Marie Schöning; Nadine Cerny; Sarah Prohaska; Max M Wittenbrink; Noel H Smith; Guido Bloemberg; Mirjam Pewsner; Irene Schiller; Francesco C Origgi; Marie-Pierre Ryser-Degiorgis
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

7.  Population estimation and trappability of the European badger (Meles meles): implications for tuberculosis management.

Authors:  Andrew W Byrne; James O'Keeffe; Stuart Green; D Paddy Sleeman; Leigh A L Corner; Eamonn Gormley; Denise Murphy; S Wayne Martin; John Davenport
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

8.  Diminishing returns in bovine tuberculosis control.

Authors:  J Hone
Journal:  Epidemiol Infect       Date:  2013-04-30       Impact factor: 4.434

9.  Surveillance and movements of Virginia opossum (Didelphis virginiana) in the bovine tuberculosis region of Michigan.

Authors:  W D Walter; J W Fischer; C W Anderson; D R Marks; T Deliberto; S Robbe-Austerman; K C Vercauteren
Journal:  Epidemiol Infect       Date:  2013-03-26       Impact factor: 4.434

10.  Linking bovine tuberculosis on cattle farms to white-tailed deer and environmental variables using Bayesian hierarchical analysis.

Authors:  W David Walter; Rick Smith; Mike Vanderklok; Kurt C VerCauteren
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.